Rifampicin is a key antibiotic for treating tuberculosis, but resistance to it is rising. Researchers tested rifampicin together with a probe compound called AAP-SO2 to try a different approach. Lab work showed AAP-SO2 binds bacterial RNA polymerase at a different site and slows the elongation step of transcription.
Because the two drugs block different steps, the team calls the idea vertical inhibition. AAP-SO2 killed bacteria with the common βS450L resistance mutation in culture and made those bacteria vulnerable to rifampicin again. In liquid culture the drugs had additive effects, but in a rabbit model they worked together much more strongly. The researchers will develop a more stable drug from the probe and have filed a provisional patent on the dual-inhibition idea.
Difficult words
- rifampicin — antibiotic used to treat tuberculosis
- resistance — ability of bacteria to survive a drug
- probe — small test compound used in experiments
- transcription — process of making RNA from DNA
- elongation — step when new RNA strand grows
- inhibition — action of stopping or slowing a process
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why is it important to find ways to treat bacteria that are resistant to antibiotics?
- What question would you ask the researchers about testing the drugs in rabbits?
- Do you think using two drugs that block different steps is a good idea? Why or why not?
Related articles
Vigorous exercise helps sleep in older adults with mild cognitive impairment
A small Texas A&M study used Oura Rings to track seven older adults with mild cognitive impairment for 14 days. Vigorous exercise gave the largest sleep benefit; light activity helped a little and moderate exercise showed no clear effect.
Gut has a backup system for IgA antibodies
Researchers found two different routes that make IgA antibodies in the gut. Early IgA often comes from non‑germinal center cells but later from germinal centers; both types showed similar specificity and mutations, which may help vaccine design.
Mpox may be spreading quietly in Nigeria
A study in Nigeria tested archived blood from healthy adults and found signs of hidden mpox exposure. Some people had old smallpox antibodies and a small number showed recent immune responses without symptoms, suggesting low-level virus circulation.
January 2025 Los Angeles wildfires and the rise in virtual health visits
A study of 3.7 million Kaiser Permanente members found that the January 2025 Los Angeles wildfires caused large increases in virtual care, especially for respiratory and cardiovascular symptoms, and raised other outpatient visits.